Skip to content (Press Enter)
ProjectZero logo
A woman holding a pair of pink Mizuno running shoes


One in eight women will be diagnosed with breast cancer in her lifetime. That’s one too many.

So let’s do something about it.

This October, in collaboration with Mizuno and the Breast Cancer Research Foundation, Fleet Feet will help raise money for breast cancer research through ProjectZero, an awareness campaign that began in 2017. The goal is to eliminate breast cancer through research and discovery.

Throughout Breast Cancer Awareness Month, Fleet Feet will sell a ProjectZero edition of Mizuno’s popular Waveknit R2 running shoe. Mizuno will then donate $10 from each shoe sale to the BCRF to help fund groundbreaking research and jump start life-changing discoveries.

The limited-edition styles are a small part of a big goal: to end the disease for good.


What is the Breast Cancer Research Foundation?

The Breast Cancer Research Foundation wants to find a cure and achieve prevention for breast cancer by advancing the world’s most promising research.

The New York-based nonprofit provides funding for cancer research around the world that fuels advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship. With an A+ rating from nonprofit watchdog Charity Watch and four out of four stars from Charity Navigator, BCRF is the highest-rated breast cancer research organization in the United States. In 2018-19, BCRF will award $63 million in grants to more than 300 scientists around the world.

Former Olympic softball player Jennie Finch is passionate about raising awareness and supporting research for breast cancer. She lost her aunt to the disease and later supported several friends through their own battles. So, for Finch, the fight is personal.

Two people run in Mizuno's Project Zero Waveknit R2